The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Healthtech.
Venture capitalsingular.vcRounds from 2024-10-09 to 2026-09-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Restate Restate is a low-latency application runtime with durable execution, keyed state, queues, RPC, timers, flow control, and operational control in one binary. | Series A Verified against 4 of 33 sources | $20M | 2026-09-30 | [ LEAD ] |
Basecamp Research A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies | Series C |
| $140M |
| 2026-09-23 |
| [ PART ] |
Basecamp Research A London AI company that trains frontier models on its proprietary Trillion Gene Atlas to design therapeutics, starting with in vivo cell therapies | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60M | 2024-10-09 | [ LEAD ] |